The Europe Animal Healthcare Market is estimated to be valued at US$ 14,096.3 million in 2023and is expected to exhibit a CAGR of 4.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
The Europe Animal Healthcare Market includes various products and services for the well-being of animals. This market offers a wide range of healthcare solutions including pharmaceuticals, vaccines, diagnostics, feed additives, and other medical devices. These products and services are targeted at preventing and treating diseases, enhancing the overall health of animals, and improving livestock production. The market caters to the growing demand for animal healthcare due to increasing pet ownership, rising prevalence of zoonotic diseases, and the need for sustainable and safe animal farming practices.
The Europe Animal Healthcare Market is driven by two main factors. Firstly, the increasing pet ownership has led to a rising demand for veterinary care and pet healthcare products. This trend is driven by the growing awareness regarding the health and well-being of pets. Secondly, rapid technological advancements in the animal healthcare industry have resulted in the development of innovative products and services. These advancements include digital health solutions, telemedicine, precision medicine, and genetic testing, which have improved the diagnosis, treatment, and management of animal diseases.
The Europe Animal Healthcare Market Size can be segmented based on product type, animal type, and distribution channel. Among these segments, the pharmaceuticals product type segment is expected to dominate the market. This can be attributed to the increasing prevalence of animal diseases, such as tick-borne diseases and zoonotic infections, which require effective medications for treatment and prevention. Additionally, the pharmaceuticals segment includes a wide range of products, such as vaccines, anti-infectives, and parasiticides, catering to the diverse healthcare needs of animals. The pharmaceuticals segment is further expected to be driven by the rising pet adoption rates and the growing demand for animal health products.
Political: Governments across Europe have implemented stringent regulations regarding the safety and efficacy of animal healthcare products. This has led to the development and commercialization of high-quality and safe products in the market.
Economic: The stable economic growth in Europe has resulted in increased disposable income, enabling pet owners to spend more on animal healthcare products and services.
Social: The increasing pet adoption rates and the growing pet humanization trend have contributed to the rise in demand for animal healthcare products in Europe.
Technological: Advances in technology have led to the development of innovative and effective animal healthcare products, such as wearable devices for remote monitoring and telemedicine solutions for veterinary care.
The Europe animal healthcare market is expected to witness high growth, exhibiting a CAGR of 4.8% over the forecast period (2023-2030). This can be attributed to the increasing prevalence of animal diseases, the rising pet adoption rates, and the growing demand for animal health products.
In terms of regional analysis, Western Europe is the fastest-growing and dominating region in the animal healthcare market. This can be attributed to the presence of a well-established healthcare infrastructure, high pet adoption rates, and increasing awareness about animal health.
Key players operating in the Europe animal healthcare market include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company. These companies are actively involved in product development, mergers and acquisitions, and strategic collaborations to strengthen their market position.